Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH Jr; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ; JAMA, 2003, vol. 289, issue 16, p 2073, ISSN 00987484. ISBN 00987484.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef